PDB ID 2BPC     CHAIN A
Protein name DNA POLYMERASE BETA
Uniprot Accession P06766
The number of similar proteins 15
The number of binding states 2
The number of binding partners 1

Coloring

Unicolor (beige)

The number of binding partners

Group

Binding
state
Binding partners
2BPC (CHAIN: A)
1 Monomeric state
2 P18887  

Downdload

Format:

Molecule viewer


Only interaction residues
#binding
partners
  1
  0

Sequence information

1   IRQDDTSSSI   NFLTRVTGIG   PSAARKLVDE   GIKTLEDLRK   NEDKLNHHQR   50
51   IGLKYFEDFE   KRIPREEMLQ   MQDIVLNEVK   KLDPEYIATV   CGSFRRGAES   100
101   SGDMDVLLTH   PNFTSESSKQ   PKLLHRVVEQ   LQKVRFITDT   LSKGETKFMG   150
151   VCQLPSENDE   NEYPHRRIDI   RLIPKDQYYC   GVLYFTGSDI   FNKNMRAHAL   200
201   EKGFTINEYT   IRPLGVTGVA   GEPLPVDSEQ   DIFDYIQWRY   REPKDRSE   250

Variants

Residue AA Source dbSNP Clinical
Significance
Allele
Frequency
(> 0.0001)
Disease name
130_ASP TYR 8.3kJPN
chr8:42213051
-
- 0.0001 -
137_ARG GLN gnomAD
chr8:42213073
rs12678588
- 0.00137809 -
137_ARG GLN 8.3kJPN
chr8:42213073
rs12678588
- 0.0025 -
160_ASP GLY 8.3kJPN
chr8:42214839
rs764645372
- 0.0001 -
185_ALA THR 8.3kJPN
chr8:42218815
-
- 0.0001 -
187_SER CYS 8.3kJPN
chr8:42218822
-
- 0.0001 -
190_ASP GLU 8.3kJPN
chr8:42218832
-
- 0.0001 -
191_MET VAL 8.3kJPN
chr8:42218833
-
- 0.0001 -
196_THR SER gnomAD
chr8:42218849
rs56121607
- 0.000739657 -
196_THR SER 8.3kJPN
chr8:42218849
rs56121607
- 0.0082 -
224_ILE VAL 8.3kJPN
chr8:42220178
rs1313860847
- 0.0002 -
233_THR ARG 8.3kJPN
chr8:42220206
-
- 0.0001 -
242_PRO ARG gnomAD
chr8:42226805
rs3136797
- 0.0105808 -
251_PRO SER 8.3kJPN
chr8:42226831
-
- 0.0001 -
255_ILE VAL gnomAD
chr8:42226843
rs184348926
- 0.000238341 -
309_GLU GLY 8.3kJPN
chr8:42229093
-
- 0.0001 -
(Powered by wupsivus)

Reference

PiSite: a database of protein interaction sites using multiple binding states in the PDB, Miho Higurashi, Takashi Ishida and Kengo Kinoshita, Nucleic Acids Research 2009 37(Database issue):D360-D364

COPYRIGHTc2008-2019 Miho Higurashi, Takashi Ishida and Kengo Kinoshita. All rights reserved.